Skip to main content
Premium Trial:

Request an Annual Quote

A Tale of Two Biotechs

A pair of articles in the Wall Street Journal today look at different forecasts for the two leading biotech companies. Amgen, "the world's largest biotech company by sales," is seeing trouble as safety questions face two of its biggest drugs. "Amgen stock has plunged, wiping out roughly $20 billion in market value since its 52-week high in October," according to this article.

Over at Genentech, meanwhile, life is cheerier. The second-biggest biotech is expected to report a nearly 40 percent spike in sales for the first quarter, this article says.


The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.